Table 2 Changes in the variables during 2-week beta-congllycinin and placebo intakes
Beta-conglycinin group (n = 8) | Placebo (n = 6) | P | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre | Post | ⊿ | Pre | Post | ⊿ | ||||||||||||||
Age (year) | 20.9 | ± | 1.2 | 21.3 | ± | 0.7 | |||||||||||||
Height (cm) | 168.9 | ± | 4.7 | 176.3 | ± | 3.7 | |||||||||||||
Weight (kg) | 59.8 | ± | 7.0 | 59.9 | ± | 6.8 | 0.2 | ± | 1.0 | 62.0 | ± | 6.3 | 62.7 | ± | 6.3 | 0.8 | ± | 1.1 | 0.337 |
BMI (kg/m²) | 20.9 | ± | 2.3 | 21.0 | ± | 2.3 | 0.1 | ± | 0.3 | 20.0 | ± | 1.7 | 20.1 | ± | 1.6 | 0.0 | ± | 0.3 | 0.769 |
Body fat (%) | 14.1 | ± | 4.6 | 14.3 | ± | 5.0 | 0.3 | ± | 1.4 | 11.6 | ± | 5.2 | 11.9 | ± | 5.2 | 0.3 | ± | 1.1 | 0.906 |
Serum metabolic parameters | |||||||||||||||||||
 Glucose (mg/dL) | 88.9 | ± | 2.3 | 90.5 | ± | 4.8 | 1.6 | ± | 4.2 | 93.8 | ± | 5.8 | 89.5 | ± | 8.4 | -4.3 | ± | 6.8 | 0.071 |
 Triglyceride (mg/dL) | 52.3 | ± | 23.4 | 69.8 | ± | 23.5 | 17.5 | ± | 23.5 | 52.2 | ± | 25.7 | 65.0 | ± | 29.9 | 12.8 | ± | 25.3 | 0.738 |
 AST (U/I) | 20.4 | ± | 2.9 | 20.6 | ± | 2.9 | 0.3 | ± | 2.9 | 20.0 | ± | 2.4 | 19.8 | ± | 1.8 | -0.2 | ± | 1.3 | 0.762 |
 ALT (U/I) | 21.4 | ± | 16.2 | 16.1 | ± | 3.5 | -5.3 | ± | 13.9 | 17.3 | ± | 6.7 | 17.7 | ± | 5.1 | 0.3 | ± | 2.3 | 0.383 |
 FGF21 (pg/mL) | 146.6 | ± | 85.0 | 158.1 | ± | 91.6 | 11.4 | ± | 85.1 | 68.0 | ± | 29.4 | 84.0 | ± | 52.2 | 16.1 | ± | 53.3 | 0.913 |
Energy and nutrients intake (/day) | |||||||||||||||||||
 Energy (kcal) | 2144 | ± | 599 | 2137 | ± | 465 | -7 | ± | 285 | 1899 | ± | 220 | 2303 | ± | 409 | 404 | ± | 671 | 0.147 |
 Protein (g) | 67.1 | ± | 20.1 | 89.4 | ± | 16.9 | 22.3 | ± | 17.7 | 70.2 | ± | 11.6 | 78.7 | ± | 11.5 | 8.5 | ± | 16.6 | 0.182 |
 Fat (g) | 74.2 | ± | 21.5 | 66.9 | ± | 17.7 | -7.2 | ± | 14.1 | 66.7 | ± | 7.6 | 86.0 | ± | 24.8 | 19.2 | ± | 34.6 | 0.075 |
 Carbohydrate (g) | 279.5 | ± | 86.4 | 280.7 | ± | 63.2 | 1.2 | ± | 45.2 | 243.6 | ± | 33.4 | 285.3 | ± | 44.2 | 41.8 | ± | 78.6 | 0.253 |
BAT activity (supraclavicular - chest skin temperature; °C) | |||||||||||||||||||
 1-h after cold exposure | 0.89 | ± | 0.28 | 0.86 | ± | 0.34 | -0.03 | ± | 0.24 | 0.90 | ± | 0.34 | 0.84 | ± | 0.35 | -0.08 | ± | 0.13 | 0.656 |
 2-h after cold exposure | 0.87 | ± | 0.31 | 0.91 | ± | 0.38 | 0.04 | ± | 0.28 | 0.77 | ± | 0.37 | 0.88 | ± | 0.39 | 0.08 | ± | 0.23 | 0.804 |